These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9855562

  • 1. Vigabatrin-associated retinal cone system dysfunction.
    Beck RW.
    Neurology; 1998 Dec; 51(6):1778-9; author reply 1779-81. PubMed ID: 9855562
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vigabatrin-associated retinal cone system dysfunction.
    Brigell MG.
    Neurology; 1998 Dec; 51(6):1779-81. PubMed ID: 9855563
    [No Abstract] [Full Text] [Related]

  • 4. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.
    Krauss GL, Johnson MA, Miller NR.
    Neurology; 1998 Mar; 50(3):614-8. PubMed ID: 9521245
    [Abstract] [Full Text] [Related]

  • 5. Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication.
    Ponjavic V, Andréasson S.
    Doc Ophthalmol; 2001 Jan; 102(1):63-72. PubMed ID: 11475366
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin.
    Ruether K, Pung T, Kellner U, Schmitz B, Hartmann C, Seeliger M.
    Arch Ophthalmol; 1998 Jun; 116(6):817-9. PubMed ID: 9639460
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Infantile spasms and vigabatrin. Visual field defects may be permanent.
    Lhatoo SD, Sander JW.
    BMJ; 1999 Jan 02; 318(7175):57. PubMed ID: 10068225
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin.
    Mackenzie R, Klistorner A.
    BMJ; 1998 Jan 17; 316(7126):233. PubMed ID: 9468717
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Severe persistent visual field constriction associated with vigabatrin.
    Eke T, Talbot JF, Lawden MC.
    BMJ; 1997 Jan 18; 314(7075):180-1. PubMed ID: 9022432
    [No Abstract] [Full Text] [Related]

  • 13. Severe persistent visual field constriction associated with vigabatrin. Benefit: risk ratio must be calculated for individual patients.
    Harding GF.
    BMJ; 1998 Jan 17; 316(7126):232-3. PubMed ID: 9468716
    [No Abstract] [Full Text] [Related]

  • 14. Severe persistent visual field constriction associated with vigabatrin. Four possible explanations exist.
    Harding GF.
    BMJ; 1997 Jun 07; 314(7095):1694. PubMed ID: 9193314
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.